Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep674 | Pituitary and Neuroendocrinology | ECE2023

Tolvaptan in the management of severe hyponatremia associated with acute intermittent porphyria

Gomez Carlos Garcia , Armengod Laura , Abad Ainhoa , Garcia Izquierdo Belen , Guzman Sanz Jorge , Rubio Ramos Miguel , Capristan Diaz Vanesa , Diez Fernandez Natalia , Palacios Nuria

Background: Acute intermittent porphyria (AIP) is an inherited autosomal dominant disorder characterized by hepatic deficiency of hydroxymethylbilane synthase (HMBS)/porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Hyponatremia is one of the main presenting symptoms and it is thought to be related to an inadequate secretion of ADH (SIADH). Since AIP is an uncommon disease, there is little information about how AIP related hyponatremia responds ...

ea0049ep948 | Pituitary - Clinical | ECE2017

Resistant prolactinomas: Retrospective study of ten cases

Castro Marta Araujo , Garcia Nuria Palacios , Pardo Javier Aller , Lopez Ainhoa Abad , Zarate Virginia Oses , Moreno Laura Mateos , Garcia Javier Estrada

About 10–15% of prolactinomas (P) are resistant to Dopamine agonists (DA). We analyzed retrospectively ten resistant prolactinomas (RP) treated at our center between 1995 and 2014, to identify useful variables to predict DA resistance and its different patterns (biochemical resistance (BR), morphological resistance (MR) or both). BR is defined as the failure to normalize prolactin (PRL) levels with ≥ 2 mg/week of cabergoline (C) for at least 3 months. MR is consider...

ea0041ep1118 | Thyroid cancer | ECE2016

Medullary thyroid cancer (MTC): descriptive analysis and prognostic factors in a multicenter study

Alcazar Victoria , Blanco Concepcion , Alvarez-Escola Cristina , Guijarro Guadalupe , Estrada Javier , De Miguel Paz , Palacios Nuria , Duran Alejandra , Carmen Montanes M. , Abad Ainhoa , Lecumberri Beatriz , Civantos Soralla , Aller Javier

Introduction: MTC accounts for 5% of thyroid cancers and can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndrome (MEN 2). The objective of our study is to evaluate the prognostic factors and outcomes of patients with MTC in the community setting.Methods: Retrospective descriptive multicenter study of patients with histological diagnosis of MTC. Descriptive, bivariate analyses (Student t for cuantitative and ...